Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 1
1977 1
1978 5
1979 6
1980 4
1981 2
1982 9
1983 5
1984 6
1985 6
1986 5
1987 12
1988 5
1989 9
1990 8
1991 9
1992 5
1993 11
1994 6
1995 5
1996 14
1997 3
1998 7
1999 10
2000 10
2001 4
2002 1
2005 1
2006 4
2007 1
2008 7
2009 3
2010 6
2011 11
2012 4
2013 8
2014 7
2015 9
2016 4
2017 10
2018 11
2019 15
2020 10
2021 15
2022 14
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for kuriya
Search for Huriya instead (1 results)
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Reply.
Kwok TSH, Kuriya B, Hawker G, Choy G, Widdifield J. Kwok TSH, et al. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2540. doi: 10.1002/acr.25188. Epub 2023 Aug 7. Arthritis Care Res (Hoboken). 2023. PMID: 37394725 No abstract available.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
[Paul-Bunnell reaction test].
Kuriya S. Kuriya S. Nihon Rinsho. 1999 Nov;57 Suppl:272-4. Nihon Rinsho. 1999. PMID: 10635832 Review. Japanese. No abstract available.
Transporter engineering in biomass utilization by yeast.
Hara KY, Kobayashi J, Yamada R, Sasaki D, Kuriya Y, Hirono-Hara Y, Ishii J, Araki M, Kondo A. Hara KY, et al. FEMS Yeast Res. 2017 Nov 1;17(7). doi: 10.1093/femsyr/fox061. FEMS Yeast Res. 2017. PMID: 28934416 Review.
Canadian Rheumatology Association Meeting Fairmont The Queen Elizabeth Montreal, Quebec, Canada February - March 2, 2019.
Silverman ED. Silverman ED. J Rheumatol. 2019 Jun 1:jrheum.190333. doi: 10.3899/jrheum.190333. Online ahead of print. J Rheumatol. 2019. PMID: 31154408 Free article.
Highlights of the meeting include the following 2019 Award Winners: Distinguished Rheumatologist, Edward Keystone; Distinguished Investigator, Diane Lacaille; Teacher-Educator, Shirley Tse; Emerging Investigator, Glen Hazlewood; Best Abstract on SLE Research by a Trainee - Ian Wa …
Highlights of the meeting include the following 2019 Award Winners: Distinguished Rheumatologist, Edward Keystone; Distinguished Investigato …
302 results